PLA2 serves as signaling molecules in certain types of malignant cancer and is associated with the initiation and progression, including prostate carcinomas, gastrointestinal and colorectal carcinomas.9, 10, 11, 12 Therefore, PLA2 has also been identified as a potential target of cancer therapy. Here, PLA2G6 is linked to prostate carcinoma.